British Columbia Cancer Agency

This study compares two ways to deliver an extra dose of radiation (called a 'boost') to men with intermediate or high-risk prostate cancer. Researchers want to see if a high-dose-rate method works as well as a low-dose-rate method at keeping cancer from returning, while causing …

This study is refining a radiation technique for early-stage breast cancer where tiny, permanent radioactive seeds are implanted directly into the breast tissue. It follows 75 women for five years to improve the procedure, measure side effects, and compare costs to other radiatio…

This study is testing a new, personalized radiation treatment for men with advanced prostate cancer that has spread and is no longer responding to standard hormone-blocking drugs. The treatment uses a radioactive drug that seeks out and delivers radiation directly to prostate can…

This study is testing whether a precise, high-dose radiation treatment (called SABR) can help people with cancer that has spread to only 1-3 other places in the body. It compares SABR against standard care to see which helps patients live longer and better. The trial also looks a…

This study compares two ways of delivering radiation directly to the prostate to treat early-stage cancer. Researchers want to see which method—a one-time implant or two separate treatments—causes fewer urinary problems and side effects while still controlling the cancer. The stu…

This study is testing a very precise, high-dose radiation treatment called SABR for people whose cancer has spread to only a few places in the body. The main goal is to carefully measure the side effects and quality of life for participants receiving this treatment. Researchers w…

This study aims to see if a blood test (liquid biopsy) works as well as or better than a standard tissue biopsy to find genetic changes in advanced cancer that can guide treatment. Researchers will compare the two methods in 1,500 patients to see which one finds more actionable t…